Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

Ionis Pharmaceuticals, Inc. Earnings Per Share (Basic)

Ionis Pharmaceuticals, Inc. (IONS) reported Earnings Per Share (Basic) of -$0.69 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-07-29

  • Ionis Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.69, a 188.46% decline year-over-year.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.56.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$1.41.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.80.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$2.38.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$3.04.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$2.56.
  • Ionis Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$1.90.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-06-30-$0.69
10-Q · filed 2026-07-29
-$1.25
10-Q · filed 2026-07-29
2026-03-31-$0.56
10-Q · filed 2026-04-29
2025-12-31-$1.41
10-K · filed 2026-02-26
$0.78
10-Q · filed 2025-07-30
-$2.38
10-K · filed 2026-02-26
2025-09-30-$0.80
10-Q · filed 2025-10-29
-$0.95
10-Q · filed 2025-10-29
2025-06-30$0.78
10-Q · filed 2026-07-29
-$0.15
10-Q · filed 2026-07-29
2025-03-31-$0.93
10-Q · filed 2026-04-29
2024-12-31-$0.66
10-K · filed 2026-02-26
-$3.04
10-K · filed 2026-02-26
2024-09-30-$0.95
10-Q · filed 2025-10-29
-$2.38
10-Q · filed 2025-10-29
2024-06-30-$0.45
10-Q · filed 2025-07-30
-$1.43
10-Q · filed 2025-07-30
2024-03-31-$0.98
10-Q · filed 2025-04-30
2023-12-31-$0.06
10-K · filed 2025-02-19
-$2.56
10-K · filed 2026-02-26
2023-09-30-$1.03
10-Q · filed 2024-11-06
-$2.50
10-Q · filed 2024-11-06
2023-06-30-$0.60
10-Q · filed 2024-08-01
-$1.47
10-Q · filed 2024-08-01
2023-03-31-$0.87
10-Q · filed 2024-05-07
2022-12-31-$0.37
10-K · filed 2024-02-21
-$1.90
10-K · filed 2025-02-19
2022-09-30-$0.33
10-Q · filed 2023-11-02
-$1.53
10-Q · filed 2023-11-02
2022-06-30-$0.74
10-Q · filed 2023-08-09
-$1.20
10-Q · filed 2023-08-09
2022-03-31-$0.46
10-Q · filed 2023-05-03
2021-12-31$1.59
10-K · filed 2023-02-22
-$0.20
10-K · filed 2024-02-21
2021-09-30-$0.58
10-Q · filed 2022-11-09
-$1.80
10-Q · filed 2022-11-09
2021-06-30-$0.57
10-Q · filed 2022-08-09
-$1.21
10-Q · filed 2022-08-09
2021-03-31-$0.64
10-Q · filed 2022-05-04
2020-12-31-$2.54
10-K · filed 2022-02-25
-$2.44
10-K · filed 2021-02-24
-$2.72
derived: net income ÷ weighted average shares · filed 2022-02-25
-$2.91
derived: net income ÷ weighted average shares · filed 2022-02-25
-$3.18
10-K · filed 2023-02-22
-$3.23
10-K · filed 2021-02-24
2020-09-30-$0.18
10-Q · filed 2021-11-03
-$0.22
10-Q · filed 2020-11-04
-$0.36
derived: net income ÷ weighted average shares · filed 2021-11-03
-$0.64
10-Q · filed 2021-11-03
-$0.80
10-Q · filed 2020-11-04
$0.67
derived: net income ÷ weighted average shares · filed 2021-11-03
2020-06-30-$0.18
10-Q · filed 2021-08-04
-$0.23
10-Q · filed 2020-08-05
-$0.47
10-Q · filed 2021-08-04
-$0.58
10-Q · filed 2020-08-05
$0.85
derived: net income ÷ weighted average shares · filed 2021-08-04
$1.03
derived: net income ÷ weighted average shares · filed 2021-08-04
2020-03-31-$0.28
10-Q · filed 2021-05-05
-$0.35
10-Q · filed 2020-05-06
$1.03
derived: net income ÷ weighted average shares · filed 2021-05-05
$1.21
derived: net income ÷ weighted average shares · filed 2021-05-05
$1.21
derived: net income ÷ weighted average shares · filed 2021-05-05
2019-12-31$1.31
10-K · filed 2021-02-24
$1.49
derived: net income ÷ weighted average shares · filed 2021-02-24
$1.49
derived: net income ÷ weighted average shares · filed 2021-02-24
$2.00
10-K · filed 2022-02-25
$2.12
10-K · filed 2020-03-02
2019-09-30$0.19
10-Q · filed 2020-11-04
$0.18
derived: net income ÷ weighted average shares · filed 2020-11-04
$0.81
10-Q · filed 2020-11-04
$3.11
derived: net income ÷ weighted average shares · filed 2020-11-04
2019-06-30-$0.01
10-Q · filed 2020-08-05
$0.62
10-Q · filed 2020-08-05
$2.93
derived: net income ÷ weighted average shares · filed 2020-08-05
$2.90
derived: net income ÷ weighted average shares · filed 2020-08-05
2019-03-31$0.63
10-Q · filed 2020-05-06
$2.95
derived: net income ÷ weighted average shares · filed 2020-05-06
$2.92
derived: net income ÷ weighted average shares · filed 2020-05-06
$2.69
derived: net income ÷ weighted average shares · filed 2020-05-06
2018-12-31$2.32
10-K · filed 2020-03-02
$2.29
derived: net income ÷ weighted average shares · filed 2020-03-02
$2.06
derived: net income ÷ weighted average shares · filed 2020-03-02
$2.09
10-K · filed 2021-02-24
2018-09-30-$0.03
10-K · filed 2020-03-02
-$0.32
derived: net income ÷ weighted average shares · filed 2020-03-02
-$0.33
10-Q · filed 2019-11-06
-$0.36
derived: net income ÷ weighted average shares · filed 2020-03-02
2018-06-30-$0.29
10-K · filed 2020-03-02
-$0.30
10-Q · filed 2019-08-08
-$0.33
derived: net income ÷ weighted average shares · filed 2020-03-02
-$0.35
derived: net income ÷ weighted average shares · filed 2020-03-02
2018-03-31-$0.01
10-K · filed 2020-03-02
-$0.03
derived: net income ÷ weighted average shares · filed 2020-03-02
-$0.05
derived: net income ÷ weighted average shares · filed 2020-03-02
-$0.08
derived: net income ÷ weighted average shares · filed 2020-03-02
2017-12-31-$0.03
10-K · filed 2019-03-01
$0.02
10-K · filed 2018-02-28
-$0.04
derived: net income ÷ weighted average shares · filed 2019-03-01
-$0.07
derived: net income ÷ weighted average shares · filed 2019-03-01
$0.15
10-K · filed 2020-03-02
$0.08
10-K · filed 2018-02-28
2017-09-30-$0.02
10-K · filed 2019-03-01
$0.00
10-Q · filed 2017-11-07
-$0.04
derived: net income ÷ weighted average shares · filed 2019-03-01
$0.13
10-Q · filed 2018-11-06
$0.02
10-Q · filed 2017-11-07
$0.24
derived: net income ÷ weighted average shares · filed 2019-03-01
2017-06-30-$0.02
10-K · filed 2019-03-01
-$0.09
10-K · filed 2018-02-28
$0.05
10-Q · filed 2018-08-07
$0.26
derived: net income ÷ weighted average shares · filed 2019-03-01
$0.32
derived: net income ÷ weighted average shares · filed 2019-03-01
2017-03-31$0.07
10-K · filed 2019-03-01
$0.03
10-Q · filed 2017-05-09
$0.29
derived: net income ÷ weighted average shares · filed 2019-03-01
$0.35
derived: net income ÷ weighted average shares · filed 2019-03-01
2016-12-31$0.21
10-K · filed 2018-02-28
$0.27
derived: net income ÷ weighted average shares · filed 2018-02-28
-$0.50
10-K · filed 2019-03-01
-$0.72
10-K · filed 2018-02-28
2016-09-30$0.06
10-K · filed 2018-02-28
-$0.93
10-Q · filed 2017-11-07
2016-06-30-$0.47
10-K · filed 2018-02-28
-$0.99
10-Q · filed 2016-08-09
2016-03-31-$0.52
10-K · filed 2018-02-28
2015-12-31-$0.59
10-K · filed 2017-03-01
-$0.74
10-K · filed 2018-02-28
2015-09-30-$0.30
10-K · filed 2017-03-01
-$0.14
10-Q · filed 2016-11-09
2015-06-30$0.30
10-K · filed 2017-03-01
$0.16
10-Q · filed 2016-08-09
2015-03-31-$0.14
10-K · filed 2017-03-01
2014-12-31$0.26
10-K · filed 2016-02-26
2014-09-30-$0.23
10-K · filed 2016-02-26
2014-06-30-$0.10
10-K · filed 2016-02-26
-$0.37
10-Q · filed 2015-08-05
2014-03-31-$0.27
10-K · filed 2016-02-26
2013-12-31-$0.21
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.42
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.52
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.55
derived: net income ÷ weighted average shares · filed 2015-03-02
2013-09-30-$0.21
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.31
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.33
derived: net income ÷ weighted average shares · filed 2014-11-07
-$0.37
derived: net income ÷ weighted average shares · filed 2015-03-02
2013-06-30-$0.09
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.11
derived: net income ÷ weighted average shares · filed 2014-08-04
-$0.14
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.51
derived: net income ÷ weighted average shares · filed 2015-03-02
2013-03-31-$0.02
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.04
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.41
derived: net income ÷ weighted average shares · filed 2015-03-02
-$0.43
derived: net income ÷ weighted average shares · filed 2015-03-02
2012-12-31-$0.03
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.40
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.41
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.65
derived: net income ÷ weighted average shares · filed 2015-03-02
2012-09-30-$0.37
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.39
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.63
derived: net income ÷ weighted average shares · filed 2013-11-05
-$0.83
derived: net income ÷ weighted average shares · filed 2014-03-03
2012-06-30-$0.01
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.25
derived: net income ÷ weighted average shares · filed 2013-08-06
-$0.45
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.72
derived: net income ÷ weighted average shares · filed 2014-03-03
2012-03-31-$0.24
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.44
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.71
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.89
derived: net income ÷ weighted average shares · filed 2014-03-03
2011-12-31-$0.20
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.47
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.65
derived: net income ÷ weighted average shares · filed 2014-03-03
-$0.85
10-K · filed 2012-02-29
2011-09-30-$0.27
10-Q · filed 2011-11-08
-$0.45
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.65
10-Q · filed 2011-11-08
-$0.79
derived: net income ÷ weighted average shares · filed 2013-02-28
2011-06-30-$0.18
10-Q · filed 2011-08-08
-$0.38
10-Q · filed 2011-08-08
-$0.52
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.65
derived: net income ÷ weighted average shares · filed 2013-02-28
2011-03-31-$0.20
10-Q · filed 2011-05-06
-$0.34
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.47
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.72
derived: net income ÷ weighted average shares · filed 2013-02-28
2010-12-31-$0.14
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.27
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.52
derived: net income ÷ weighted average shares · filed 2013-02-28
-$0.62
10-K · filed 2012-02-29
2010-09-30-$0.13
10-Q · filed 2011-11-08
-$0.38
derived: net income ÷ weighted average shares · filed 2012-02-29
-$0.48
10-Q · filed 2011-11-08
2010-06-30-$0.25
10-Q · filed 2011-08-08
-$0.35
10-Q · filed 2011-08-08
2010-03-31-$0.10
10-Q · filed 2011-05-06
2009-12-31$1.58
10-K · filed 2012-02-29
2009-09-30-$0.12
10-Q · filed 2010-11-05
$1.75
10-Q · filed 2010-11-05
2009-06-30-$0.03
10-Q · filed 2010-08-09
$1.88
10-Q · filed 2010-08-09
2008-12-31-$0.19
10-K · filed 2011-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10